
Immuron hit with 44% first strike vote
Pontos principais
- Immuron has received a first strike, with 43.58% of votes cast against its 2026 remuneration report.
- Shareholders also rejected an incentive plan renewal and a bid for more placement capacity.
- Immuron faces a possible board spill vote if its remuneration report draws another strike at next year’s AGM.
Immuron (ASX:IMC) received a first strike at its AGM, with 43.58% of votes cast against its 2026 remuneration report.
The vote came after the CEO’s AGM presentation showed FY27 sales to October up 10% to A$3.0 million, although US sales fell 19%.
Shareholders also rejected the renewal of Immuron’s Omnibus Incentive Plan, with 50.99% of votes against.
A special resolution to increase the company’s placement capacity failed with 65.62% support, short of the 75% it needed.
A second strike at next year’s AGM would trigger a vote on whether to spill the board.
Following the announcement the Immuron share price was unchanged at $0.037.
Shareholders re-elected director Dr Jeannette Joughin with 33.83% of votes against, and rejected Param Lally, a candidate the board did not endorse, with 70.33% against.
Immuron is a biopharmaceutical company whose main product, Travelan, aims to reduce the risk of travellers’ diarrhoea and is sold in Australia, the US and Canada.


